-
1
المؤلفون: Jason Gotlib, Cem Akin, Alberto Orfao, Peter Valent, Mohamad Jawhar, Hanneke C. Kluin-Nelemans, Patrizia Bonadonna, Frank Siebenhaar, Michel Arock, Bogusław Nedoszytko, Roberta Zanotti, Juliana Schwaab, Sigurd Broesby-Olsen, Andreas Reiter, Marek Niedoszytko, Joseph H. Butterfield, Olivier Hermine, Massimo Triggiani, Hans-Peter Horny, Karl Sotlar, Mariana Castells, Knut Brockow, Karin Hartmann, Wolfgang R. Sperr, Iván Álvarez-Twose, Dean D. Metcalfe
المصدر: Journal of Allergy and Clinical Immunology, 146(2), 300-306. MOSBY-ELSEVIER
The Journal of Allergy and Clinical Immunology
Valent, P, Akin, C, Bonadonna, P, Brockow, K, Niedoszytko, M, Nedoszytko, B, Butterfield, J H, Alvarez-Twose, I, Sotlar, K, Schwaab, J, Jawhar, M, Reiter, A, Castells, M, Sperr, W R, Kluin-Nelemans, H C, Hermine, O, Gotlib, J, Zanotti, R, Broesby-Olsen, S, Horny, H P, Triggiani, M, Siebenhaar, F, Orfao, A, Metcalfe, D D, Arock, M & Hartmann, K 2020, ' Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic : Expert opinions ', Journal of Allergy and Clinical Immunology, vol. 146, no. 2, pp. 300-306 . https://doi.org/10.1016/j.jaci.2020.06.009
Journal of Allergy and Clinical Immunologyمصطلحات موضوعية: 0301 basic medicine, MIDOSTAURIN, coronavirus, COVID-19, KIT D816V, mast cell activation syndrome, Mast cells, mastocytosis, SARS-CoV-2, tryptase, Betacoronavirus, Comorbidity, Coronavirus Infections, Diphosphonates, Expert Testimony, Glucocorticoids, Histamine Antagonists, Humans, Immunosuppressive Agents, Mast Cells, Mastocytosis, Cutaneous, Mastocytosis, Systemic, Myeloablative Agonists, Pneumonia, Viral, Precision Medicine, Risk Factors, Vitamin D, Disease Management, Pandemics, medicine.medical_treatment, Hematopoietic stem cell transplantation, Disease, medicine.disease_cause, MCA, Mast cell activation, 0302 clinical medicine, Pandemic, INFECTION, Immunology and Allergy, CRITERIA, Viral, 030212 general & internal medicine, Systemic mastocytosis, MCAS, Mast cell activation syndrome, Coronavirus, BM, Bone marrow, CM, Cutaneous mastocytosis, SAFETY, MAST-CELLS, medicine.symptom, CELL ACTIVATION SYNDROMES, medicine.medical_specialty, DISORDERS, Immunology, Mast cell activation syndrome, DIAGNOSIS, Article, WHO, World Health Organization, CLASSIFICATION, KITD816V, 03 medical and health sciences, medicine, Intensive care medicine, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, Corona Virus, business.industry, Cutaneous Mastocytosis, Systemic, Pneumonia, medicine.disease, EFFICACY, Cutaneous, 030104 developmental biology, IgE, Immunoglobulin E, MC, Mast cells, SM, Systemic mastocytosis, COVID-19, Corona virus disease 2019, business, ISM, Indolent systemic mastocytosis
وصف الملف: application/pdf
-
2
المؤلفون: Julien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, Stéphane Barete, Louis Terriou, David Launay, Richard Lemal, Celine Greco, Laurent Frenzel, Cecile Meni, Christine Bodemere-Skandalis, Laura Polivka, Anne-Florence Collange, Hassiba Hachichi, Sonia Bouzourine, Djazira Nait Messaoud, Mathilde Negretto, Laurence Vendrame, Marguerite Jambou, Marie Gousseff, Stéphane Durupt, Jean-Christophe Lega, Jean-Marc Durand, Caroline Gaudy, Gandhi Damaj, Marie-Pierre Gourin, Mohamed Hamidou, Laurence Bouillet, Edwige Le Mouel, Alexandre Maria, Patricia Zunic, Quentin Cabrera, Denis Vincent, Christian Lavigne, Etienne Riviere, Clement Gourguechon, Marie Courbebaisse, David Lebeaux, Béatrice Parfait, Gérard Friedlander, Anne Brignier, Ludovic Lhermitte, Thierry Jo Molina, Julie Bruneau, Julie Agopian, Patrice Dubreuil, Dana Ranta, Alexandre Mania, Michel Arock, Isabelle Staropoli, Olivier Tournilhac, Olivier Lortholary, Olivier Schwartz, Lucienne Chatenoud, Olivier Hermine
المساهمون: Centre de référence des mastocytoses (CEREMAST), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Référence des Mastocytoses de Toulouse (CEREMAST), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias (CHELTER), Université Clermont Auvergne (UCA), Virus et Immunité - Virus and immunity (CNRS-UMR3569), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), The authors would like to thank Fondation Université de Paris, AXA research fund, Fondation Hôpitaux de Paris-Hôpitaux de France, Mécénat du GH APHP. CUP, Fondation pour la Recherche en Physiologie and DMU BioPhyGen for the funding of the COVID-HOP study., ANR-20-COV1-0001,APCOD,Les cellules présentatrices d'antigènes dans la maladie de COVID-19 à résolution monocellulaire(2020), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPC), CHU Toulouse [Toulouse], Virus et Immunité - Virus and immunity, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)
المصدر: The Journal of Allergy and Clinical Immunology. in Practice
The Journal of Allergy and Clinical Immunology: In Practice
The Journal of Allergy and Clinical Immunology: In Practice, 2022, 10 (5), pp.1356-1364.e2. ⟨10.1016/j.jaip.2021.12.038⟩
The Journal of Allergy and Clinical Immunology: In Practice, American Academy of Allergy, Asthma & Immunology, 2022, 10 (5), pp.1356-1364.e2. ⟨10.1016/j.jaip.2021.12.038⟩مصطلحات موضوعية: PBMC, peripheral blood mononuclear cell, BMI, body mass index, T cells, B-cells, CEREMAST, Centre de Référence des Mastocytoses, CM, cutaneous mastocytosis, MMAS, monoclonal mast cell activation syndrome, PHA, phytohemagglutinin, PMSI, Programme de médicalisation des systèmes d'information, Antibodies, Viral, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, Antiviral Agents, WHO, World Health Organization, MIS, mastocytosis in the skin, HEK, human embryonic kidney, Humans, Immunology and Allergy, IFN, interferon, Mast Cells, APHP, Assistance Publique - Hôpitaux de Paris (Paris Public Hospital Group), B cells, SARS-CoV-2, T-cells, Immunity, COVID-19, ISM, indolent systemic mastocytosis, Clonal mast cell activation syndrome, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, MCAS, mast cell activation syndrome, Original Article, Mast cell activation dis- orders, SSM, smoldering systemic mastocytosis, NK, natural killer, Mastocytosis, COVID-19, coronavirus disease 19, Mast cell activation disorders, cMCAD, clonal mast cell activation disorder